Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: two-year prospective cohort study

被引:86
作者
Warkentin, Lindsey M. [1 ,2 ]
Majumdar, Sumit R. [1 ,2 ,3 ]
Johnson, Jeffrey A. [2 ,3 ]
Agborsangaya, Calypse B. [2 ,3 ]
Rueda-Clausen, Christian F. [1 ,2 ]
Sharma, Arya M. [1 ,2 ]
Klarenbach, Scott W. [1 ,2 ]
Karmali, Shahzeer [4 ,5 ]
Birch, Daniel W. [4 ,5 ]
Padwal, Raj S. [1 ,2 ]
机构
[1] Univ Alberta, Dept Med, Edmonton, AB, Canada
[2] Alberta Diabet Inst, Edmonton, AB, Canada
[3] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada
[4] Univ Alberta, Royal Alexandra Hosp, Sch Publ Hlth, Edmonton, AB, Canada
[5] Univ Alberta, Royal Alexandra Hosp, Ctr Adv Minimally Invas Surg, Edmonton, AB, Canada
来源
BMC MEDICINE | 2014年 / 12卷
基金
加拿大健康研究院;
关键词
Health-related quality of life; Weight loss; Minimal clinically important difference; Obesity; Patient reported outcomes; Bariatric care; BARIATRIC SURGERY; OUTCOMES; MORTALITY; DISEASE; DESIGN; IMPACT;
D O I
10.1186/s12916-014-0175-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Guidelines and experts describe 5% to 10% reductions in body weight as 'clinically important'; however, it is not clear if 5% to 10% weight reductions correspond to clinically important improvements in health-related quality of life (HRQL). Our objective was to calculate the amount of weight loss required to attain established minimal clinically important differences (MCIDs) in HRQL, measured using three validated instruments. Methods: Data from the Alberta Population-based Prospective Evaluation of Quality of Life Outcomes and Economic Impact of Bariatric Surgery (APPLES) study, a population-based, prospective Canadian cohort including 150 wait-listed, 200 medically managed and 150 surgically treated patients were examined. Two-year changes in weight and HRQL measures (Short-Form (SF)-12 physical (PCS; MCID = 5) and mental (MCS; MCID = 5) component summary score, EQ-5D Index (MCID = 0.03) and Visual Analog Scale (VAS; MCID = 10), Impact of Weight on Quality of Life (IWQOL)-Lite total score (MCID = 12)) were calculated. Separate multivariable linear regression models were constructed within medically and surgically treated patients to determine if weight changes achieved HRQL MCIDs. Pooled analysis in all 500 patients was performed to estimate the weight reductions required to achieve the pre-defined MCID for each HRQL instrument. Results: Mean age was 43.7 (SD 9.6) years, 88% were women, 92% were white, and mean initial body mass index was 47.9 (SD 8.1) kg/m(2). In surgically treated patients (two-year weight loss = 16%), HRQL MCIDs were reached for all instruments except the SF-12 MCS. In medically managed patients (two-year weight loss = 3%), MCIDs were attained in the EQ-index but not the other instruments. In all patients, percent weight reductions to achieve MCIDs were: 23% (95% confidence interval (CI): 17.5, 32.5) for PCS, 25% (17.5, 40.2) for MCS, 9% (6.2, 15.0) for EQ-Index, 23% (17.3, 36.1) for EQ-VAS, and 17% (14.1, 20.4) for IWQOL-Lite total score. Conclusions: Weight reductions to achieve MCIDs for most HRQL instruments are markedly higher than the conventional threshold of 5% to 10%. Surgical, but not medical treatment, consistently led to clinically important improvements in HRQL over two years.
引用
收藏
页数:9
相关论文
共 30 条
  • [1] Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery
    Adams, TD
    Avelar, E
    Cloward, T
    Crosby, RD
    Farney, RJ
    Gress, R
    Halverson, RC
    Hopkins, PN
    Kolotkin, RL
    LaMonte, MJ
    Litwin, S
    Nuttall, RT
    Pendleton, R
    Rosamond, W
    Simper, SC
    Smith, SC
    Strong, M
    Walker, JM
    Wiebke, G
    Yanowitz, FG
    Hunt, SC
    [J]. CONTEMPORARY CLINICAL TRIALS, 2005, 26 (05) : 534 - 551
  • [2] [Anonymous], IMP WEIGHT QUAL LIF
  • [3] Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
    Bastien, Marjorie
    Poirier, Paul
    Lemieux, Isabelle
    Despres, Jean-Pierre
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2014, 56 (04) : 369 - 381
  • [4] Christou NV, 2009, CAN J SURG, V52, P229
  • [5] Defining clinically meaningful change in health-related quality of life
    Crosby, RD
    Kolotkin, RL
    Williams, GR
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (05) : 395 - 407
  • [6] *EUROQOL GROUP, EQ 5D STAND INSTR US
  • [7] MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE
    JAESCHKE, R
    SINGER, J
    GUYATT, GH
    [J]. CONTROLLED CLINICAL TRIALS, 1989, 10 (04): : 407 - 415
  • [8] Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee
  • [9] Prevalence of class I, II and III obesity in Canada
    Katzmarzyk, PT
    Mason, C
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (02) : 156 - 157
  • [10] Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x